Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Current Assets (2016 - 2025)

U S Physical Therapy's Current Assets history spans 12 years, with the latest figure at $228.5 million for Q3 2023.

  • For Q3 2023, Current Assets rose 102.4% year-over-year to $228.5 million; the TTM value through Sep 2023 reached $228.5 million, up 102.4%, while the annual FY2022 figure was $111.3 million, 16.92% up from the prior year.
  • Current Assets for Q3 2023 was $228.5 million at U S Physical Therapy, down from $241.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $241.8 million in Q2 2023 and bottomed at $75.8 million in Q1 2021.
  • The 5-year median for Current Assets is $95.2 million (2021), against an average of $112.5 million.
  • The largest annual shift saw Current Assets tumbled 49.02% in 2021 before it soared 102.4% in 2023.
  • A 5-year view of Current Assets shows it stood at $85.4 million in 2019, then grew by 2.64% to $87.6 million in 2020, then grew by 8.59% to $95.2 million in 2021, then rose by 16.92% to $111.3 million in 2022, then skyrocketed by 105.36% to $228.5 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Current Assets are $228.5 million (Q3 2023), $241.8 million (Q2 2023), and $117.8 million (Q1 2023).